Does CASPOFUNGIN Cause Malignant neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with CASPOFUNGIN (CASPOFUNGIN ACETATE). This represents 0.2% of all adverse event reports for CASPOFUNGIN.
8
Reports of Malignant neoplasm progression with CASPOFUNGIN
0.2%
of all CASPOFUNGIN reports
6
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CASPOFUNGIN?
Of the 8 reports, 6 (75.0%) resulted in death, 2 (25.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CASPOFUNGIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does CASPOFUNGIN Cause?
Drug ineffective (1,060)
Off label use (325)
Product use in unapproved indication (257)
Multiple organ dysfunction syndrome (215)
Drug resistance (194)
Septic shock (165)
Aspergillus infection (154)
Drug reaction with eosinophilia and systemic symptoms (136)
Systemic mycosis (129)
Pyrexia (128)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CASPOFUNGIN Alternatives Have Lower Malignant neoplasm progression Risk?
CASPOFUNGIN vs CATEQUENTINIB
CASPOFUNGIN vs CC-4047
CASPOFUNGIN vs CEDAZURIDINE\DECITABINE
CASPOFUNGIN vs CEDIRANIB
CASPOFUNGIN vs CEFACLOR